Impact of Dapagliflozin as Add-on Therapy on Glycemic Status and Quality of Life in Type 2 Diabetic Patients
NCT06326034
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Diabetic Nephropathy Type 2
Interventions
DRUG:
Dapagliflozin
Sponsor
Mohammed Mahmood Mohammed